Karcinom prostaty a radikální prostatektomie

27 Miloš Broďák a kol. 3 Základní fakta o karcinomu prostaty 34. Král M, Študent V, Vidlář A, Hrabec M, Marek D. Nomogram predikce up- -gradingu Gleasonova skóre v biopsii prostaty. Ces Urol 2007; 11: 82–86. 35. Chao KK, Goldstein NS, Yan D, Vargas CE, Ghilezan MI, Korman HJ, Kernen KM, Hollander JB, Gonzalez JA, Martinez AA, Vicini FA, Kestin LL. Clinicopathologic analysis of extracapsular extension in prostate cancer: should the clinical target volume be expanded posterolaterally to account for microscopic extension? Int J Radiat Oncol Biol Phys. 2006; 65: 999–1007. 36. Hernandez DJ, Nielsen ME, Han M, Partin AW. Contemporary evaluation of the D’amico risk classification of prostate cancer. Urology. 2007; 70: 931–935. 37. D’Amico AV, Whittington R, Malkowicz SB, Cote K, Loffredo M, Schultz D, Chen MH, Tomaszewski JE, Renshaw AA, Wein A, Richie JP. Biochemical outcome after radical prostatectomy or external beam radiation therapy for patients with clinically localized prostate carcinoma in the prostate specific antigen era. Cancer. 2002; 95: 281–286. 38. Hurwitz MD, Schultz D, Richie JP, Wein AJ, Whittington R, Malkowicz SB, D’Amico AV. Radical prostatectomy for high-grade prostate cancer. Urology 2006; 68: 367–370. 39. Brodak M, Kosina J, Holub L, Louda M, Odrazka K, Dolezel M, Sefrová J, Jansa J, Pacovsky J. Radical prostatectomy in high-grade prostate cancer, salvage and adjuvant radiotherapy. Urol Int. 2011; 86: 146–151.